Brokerages Set MBX Biosciences, Inc. (NYSE:MBX) PT at $37.50
Shares of MBX Biosciences, Inc. (NYSE:MBX – Get Free Report) have been assigned a consensus recommendation of “Buy” from the six brokerages that are covering the company, MarketBeat.com reports. Six equities research analysts have rated the stock with a buy rating. The average 12 month target price among analysts that have updated their coverage on […]
Shares of MBX Biosciences, Inc. (NYSE:MBX – Get Free Report) have been assigned a consensus recommendation of “Buy” from the six brokerages that are covering the company, MarketBeat.com reports. Six equities research analysts have rated the stock with a buy rating. The average 12 month target price among analysts that have updated their coverage on […]
